Followers | 15 |
Posts | 151 |
Boards Moderated | 0 |
Alias Born | 06/20/2020 |
Sunday, January 24, 2021 7:16:29 PM
Psychedelic drugs are going mainstream fast, with research supporting their effectiveness in alleviating emotional problems. Scientists continue to revisit different psychedelics such as LSD, magic mushrooms and other therapeutics for a range of mental ailments. Research is in full swing with the announcement from Johns Hopkins on its development of the Center for Psychedelic and Consciousness Research.
I recommend you take a moment and click here and discover how you can get this stock’s name & ticker symbol.
http://www.icontact-archive.com/archive?c=865021&f=14629&s=19386&m=538224&t=06648922036e02f7f04a2684ef5de698b9328bbc84174897a2dc6366aad296b8
If I told you that psychedelic stocks were among some of the best stocks to buy for the next decade, you’d probably look at me funny. I wouldn’t blame you. But, believe it or not, psychedelic stocks are some of the best stocks to buy for the next 10 years. Here is where you need to go now to get the name of this secret stock before everyone else.
This specific secret company is making incredible strides in this sector. It is focused on bringing targeted medicine to market, through novel delivery systems, psychedelic assisted psychotherapy, and Active Pharmaceutical Ingredient grade psilocybin manufacturing. To that effect, while it is still early in the medicinal psychedelic space, hefty valuations are being placed on the most serious contenders competing for a slice of the $100 billion pie.
This Secret Company with a market capitalization of less than $30 million CAD, provides investors with an opportunity which could prove highly lucrative as the industry develops and matures! Just make sure you own a piece of it before it is too late.
Click Here to review a thorough report detailing the above on this "Secret Company" and discover for yourself why you need to invest in it right away!
http://www.icontact-archive.com/archive?c=865021&f=14629&s=19386&m=538224&t=06648922036e02f7f04a2684ef5de698b9328bbc84174897a2dc6366aad296b8
Sincerely,
Editor In Chief, OTCtipReporter Team
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM